499.88
5.73%
27.08
アフターアワーズ:
499.88
Vertex Pharmaceuticals Inc (VRTX) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
6.87%
2,690.60
|
2,517.70 | 2,483.50 | 2,493.20 | 2,374.80 |
Cost Of Revenue |
6.90%
342.60
|
368.00 | 318.70 | 308.60 | 266.90 |
Gross Profit |
9.22%
2,348.00
|
2,149.70 | 2,164.80 | 2,184.60 | 2,107.90 |
Operating Expenses
|
4.07%
1,208.50
|
1,161.20 | 1,126.70 | 1,158.20 | 1,328.90 |
Benefits Costs and Expenses |
3.02%
1,411.50
|
1,370.10 | 1,304.30 | 1,331.70 | 1,483.30 |
Costs And Expenses |
1.43%
1,551.10
|
1,529.20 | 1,445.40 | 1,466.80 | 1,595.80 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
15.28%
1,139.50
|
988.50 | 1,038.10 | 1,026.40 | 779.00 |
Net Interest Income/Expense |
1.89%
-10.40
|
-10.60 | -10.90 | -11.20 | -11.40 |
Interest Income/Expense After Provision For Losses |
1.89%
-10.40
|
-10.60 | -10.90 | -11.20 | -11.40 |
Income/Loss From Continuing Operations Before Tax |
11.46%
1,279.10
|
1,147.60 | 1,179.20 | 1,161.50 | 891.50 |
Income Tax Expense/Benefit |
0.39%
179.50
|
178.80 | 143.90 | 245.80 | 191.70 |
Income/Loss From Continuing Operations After Tax |
13.50%
1,099.60
|
968.80 | 1,035.30 | 915.70 | 699.80 |
Net Income/Loss
|
13.50%
1,099.60
|
968.80 | 1,035.30 | 915.70 | 699.80 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
258.20
|
- | 258.00 | 257.70 | 257.40 |
Diluted Average Shares |
261.00K%
261.10
|
0.10 | 260.60 | 260.40 | 260.30 |
Basic Earnings Per Share |
13.30%
4.26
|
3.76 | 4.01 | 3.55 | 2.72 |
Diluted Earnings Per Share |
13.48%
4.21
|
3.71 | 3.97 | 3.52 | 2.69 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):